Day: February 7, 2022
DALLAS, Feb. 07, 2022 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (Nasdaq: TBK) (“Triumph” or the “Company”) announced today that its board of directors has authorized the Company to repurchase up to $50 million of its outstanding common stock. The Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions at the Company’s discretion. The amount, timing and nature of any share repurchases will be based on a variety of factors, including the trading price of the Company’s common stock, applicable securities laws restrictions, regulatory limitations and market and economic factors. The repurchase program is authorized for a period of up to one year and does not require the Company to repurchase any specific number of shares. The repurchase program may be modified, suspended...
BIO-key’s PortalGuard Identity and Access Control Platform Adds New Mexico’s Rio Arriba County to Growing List of County Government Customers Throughout the US
Written by Customer Service on . Posted in Public Companies.
BIO-key’s PIV-Pro fingerprint readers selected for office users and WEB-key’s MobileAuth with PalmPositive Application for remote users
WALL, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced in partnership with iT1 that Rio Arriba County, NM has selected its PortalGuard IAM platform, including WEB-key biometric authentication, to deliver cost-effective, modern security controls for access to all its enterprise resources and mission-critical applications. The County also chose BIO-key’s PIV-Pro fingerprint readers, a highly accurate FIPS 201 compliant scanner for its office users, and remote users will use WEB-key’s MobileAuth...
Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2021 Total Revenues; Provides 2022 Total Revenue Guidance and Corporate Update
Written by Customer Service on . Posted in Public Companies.
2021 Total Revenues Estimated at $141 Million, Representing 18% YoY Growth
Forecast 2022 Total Revenues of Between $195 Million and $205 Million, Representing YoY Growth of 38% to 45%
Recently Regained Orphan Drug Exclusivity in the U.S. for Amifampridine to Treat LEMS
Entering 2022 with a Strong Cash Position of Approximately $191 Million and No Funded Debt
Poised to Acquire Products, Pipeline and/or Companies in 2022
CORAL GABLES, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today provided preliminary 2021 fourth quarter and full year total revenue estimates, a forecast of 2022 total revenue...
Graphex Group, a Global Supplier of Graphite, Announces Plans to Establish a Michigan-based EV Battery Materials Production Facility
Written by Customer Service on . Posted in Public Companies.
Graphex Group’s exclusive MOU with Emerald Energy Solutions LLC is a key step toward the construction of a graphite processing facility in the greater Michigan area to support EV battery production across the United States
ROYAL OAK, Mich., Feb. 07, 2022 (GLOBE NEWSWIRE) — Graphex Technologies, LLC, a wholly owned subsidiary of Graphex Group Limited (collectively “Graphex”) (OTCQX: GRFXY | HKSE: 6128), has entered into an exclusive non-binding memorandum of understanding (MOU) to form a joint venture with Michigan-based Emerald Energy Solutions LLC (“EES”) for constructing and operating a graphite processing facility. The joint venture is considering several Michigan sites as well as other sites for the facility. Final decision and site selection is expected in March and is subject to agreements being reached with state and local...
Global Pulse Oximeters Market Size [2022-2025] | to Reach USD 2,657.6 Million, at a CAGR 6.7%
Written by Customer Service on . Posted in Mergers And Acquisitions.
Pulse Oximeters Market is projected to grow USD 2,657.6 Million in 2025 at a CAGR of 6.7% during the 2022-2025 period
Pune, India, Feb. 07, 2022 (GLOBE NEWSWIRE) — The global pulse oximeters market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled “Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to reach US$ 2,657.6 Mn by the end of 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period.
In the report, Fortune Business Insights has profiled a few companies that are operating in the global pulse oximeter market. Some of the leading companies that have been...
Global Hormone Replacement Therapy Market Size [2022-2028] | to Reach USD 14.17 Billion, at a CAGR 6.1%
Written by Customer Service on . Posted in Mergers And Acquisitions.
Hormone Replacement Therapy Market projected to grow from USD 14.17 billion in 2021 to USD 21.49 billion in 2028 at a CAGR of 6.1% in the 2022-2028 period.
Pune, India, Feb. 07, 2022 (GLOBE NEWSWIRE) — The global hormone replacement therapy market size was USD 13.40 billion in 2020. The market is projected to grow from USD 14.17 billion in 2021 to USD 21.49 billion in 2028 at a CAGR of 6.1% in the 2022-2028 period. This information is provided by Fortune Business Insights, in its report titled, “Hormone Replacement Therapy Market, 2022-2028.”
According to our expert analysts, the market is witnessing growth, owing to its development in several other hormone-associated illnesses concerned with diverse age groups that are impacting both, women as well as men.
Industry Developments:
May 2021: Myovant Sciences GmbH declared that it...
Blue Star Foods Corp. to Present at Aegis Virtual Conference
Written by Customer Service on . Posted in Public Companies.
Miami, Florida, Feb. 07, 2022 (GLOBE NEWSWIRE) — Blue Star Foods Corp., (NASDAQ: BSFC) (“Blue Star” or “BSFC”), an integrated Environmental, Social, and Governance (ESG) seafood company, announced today that, John Keeler, CEO of Blue Star Foods will be presenting at the Aegis Virtual Conference which is taking place for three days, February 23, 2022 until February 25, 2022, from 8:30AM until 5PM EST.
See details below about Blue Star Food’s presentation:
Event: Aegis Capital Virtual Conference
Location: Virtual
Date: Friday, February 23, 2022
Time: 1:00 p.m. – 1:30 p.m. ET (Presentation and Q&A)
To access the event, please download and import the following iCalendar (.ics) files to your calendar system: Aegis Virtual Conference Calendar
About Blue Star Foods Corp.
Blue Star Foods Corp. is an integrated ESG seafood company...
BioRestorative Therapies to Ring Nasdaq Stock Market Closing Bell
Written by Customer Service on . Posted in Public Companies.
MELVILLE, N.Y., Feb. 07, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical-stage company focused on stem cell-based therapies, today announced that Lance Alstodt, BioRestorative’s Chairman and CEO, along with Francisco Silva, Vice President of Research and Development, have been invited to ring the closing bell at Nasdaq’s stock market closing on Monday, February 7th at 4:00 PM ET in celebration of BioRestoriative’s uplisting to Nasdaq.
The ceremony will begin at approximately 3:45PM ET and can be viewed live at https://livestream.com/accounts/27896496/events/9988418 .
“We are honored to ring the closing bell in celebration of our recent uplisting. Our goal is to validate our technology through the regulatory process positioning the Company as a leader in...
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022
Written by Customer Service on . Posted in Public Companies.
CANTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that fourth quarter and fiscal year 2021 financial results will be reported after the market closes on Tuesday, March 1st.
Management will host a conference call at 5:00 p.m. Eastern Time on March 1st to discuss the results of the quarter and fiscal year, and provide a corporate update with a question and answer session. Those who would like to participate may dial 866-795-3142 (409-937-8908 for international callers) and provide access code 5998131. A live webcast of the call will also be provided on the investor relations section...
MariMed Top-Selling Brands and Products Now Available in Delaware
Written by Customer Service on . Posted in Public Companies.
NORWOOD, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced that its award-winning cannabis brands and products are now available in Delaware. As a result of new regulations in the Delaware Medical Marijuana program, MariMed has expanded its licensing agreement with First State Compassion Center (“FSC”), a leading Delaware vertically integrated cannabis operator, to produce and distribute its branded cannabis edibles.
First State Compassion will have exclusive rights to produce and distribute MariMed’s Betty’s Eddies® infused fruit chews, Bubby’s Baked™ soft and chewy, full-spectrum cannabis baked bites, and k FUSION chewable micro-dose mints. MariMed and FSC have a longstanding advisory relationship....